Clinical Trials for CRI

Explore 334 clinical trials worldwide

Showing 1-50 of 334 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CRI

Clinical Trials (334)

NCT04933422
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PHASE1Not yet recruiting
72 participants
Started: Jan 31, 2027 · Completed: Jul 31, 2029
1 condition1 sponsor0 locations
NCT05122325
Treatment for Sexual Dysfunction in Women with Spinal Cord Injury
NAEnrolling by invitation
54 participants
Started: Jun 30, 2026 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT07189728
The MagnaSafe-2 Registry: Assessing the Risks of Magnetic Resonance Imaging in Three Patient Groups
N/ANot yet recruiting
1,500 participants
Started: Jan 1, 2026 · Completed: Jan 1, 2031
3 conditions1 sponsor0 locations
NCT07092267
Safety and Efficacy Evaluation of ArtiFix® Sealant Graft in Subjects Requiring Dural Repair Following Neurosurgery
NANot yet recruiting
20 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
2 conditions2 sponsors0 locations
NCT06206616
Liver Steatosis in Pediatric CD Patients
N/ANot yet recruiting
91 participants
Started: Nov 1, 2025 · Completed: Sep 30, 2028
2 conditions3 sponsors2 locations
NCT05874193
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
PHASE2Not yet recruiting
33 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor5 locations
NCT07111988
Valbenazine in Obsessive Compulsive Disorder
PHASE2Not yet recruiting
30 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition2 sponsors0 locations
NCT06686771
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
PHASE3Not yet recruiting
320 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2030
1 condition5 sponsors14 locations
NCT07087054
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
PHASE3Recruiting
141 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2030
9 conditions1 sponsor10 locations
NCT07129252
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
PHASE1/PHASE2Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2029
3 conditions1 sponsor0 locations
NCT07065721
Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
NARecruiting
40 participants
Started: Oct 2, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT07208838
Validation of DDIVAT Digital Optotypes for Distance Visual Acuity Testing Among the Bulgarian Population
N/AEnrolling by invitation
150 participants
Started: Oct 1, 2025 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT07200245
Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
N/ANot yet recruiting
522 participants
Started: Oct 1, 2025 · Completed: Dec 31, 2027
3 conditions3 sponsors0 locations
NCT07128082
The Long COVID Treatment Trial
PHASE2Not yet recruiting
1,000 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors0 locations
NCT07159841
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
PHASE2/PHASE3Not yet recruiting
153 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2030
2 conditions1 sponsor0 locations
NCT07115563
Daily Amino Acid Supplementation for People With Parkinson's Disease
NANot yet recruiting
30 participants
Started: Sep 30, 2025 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT07157384
REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
NANot yet recruiting
176 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors6 locations
NCT07144163
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
PHASE3Not yet recruiting
150 participants
Started: Sep 30, 2025 · Completed: May 31, 2027
2 conditions1 sponsor5 locations
NCT06625801
IVUS CHIP UPP Registry
N/ANot yet recruiting
1,010 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2029
3 conditions3 sponsors0 locations
NCT07011576
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
PHASE2Recruiting
60 participants
Started: Sep 29, 2025 · Completed: Jun 30, 2027
4 conditions2 sponsors10 locations
NCT07187375
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
PHASE2Not yet recruiting
6 participants
Started: Sep 28, 2025 · Completed: Oct 4, 2029
1 condition1 sponsor0 locations
NCT07132645
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
EARLY_PHASE1Recruiting
30 participants
Started: Sep 16, 2025 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT07154225
INcreasing Adolescent Social and Community SupporT - Full Trial
NANot yet recruiting
215 participants
Started: Sep 15, 2025 · Completed: Jun 30, 2027
1 condition4 sponsors0 locations
NCT06992258
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
PHASE2Not yet recruiting
120 participants
Started: Sep 15, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor0 locations
NCT07143383
CAMHS and Social Prescribing Applications
NANot yet recruiting
120 participants
Started: Sep 15, 2025 · Completed: May 31, 2027
1 condition3 sponsors0 locations
NCT06694753
Safety and Immunogenicity of mRNAs Encoding HIV Immunogens (eOD-GT8 60mer, Core-g28v2 60mer, N332-GT5 gp151) in Adult Participants Without HIV and in Overall Good Health in South Africa (HVTN 317)
PHASE1Not yet recruiting
96 participants
Started: Sep 9, 2025 · Completed: Dec 19, 2025
1 condition8 sponsors8 locations
NCT07106281
Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial
NANot yet recruiting
30 participants
Started: Sep 1, 2025 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06975020
Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
NANot yet recruiting
120 participants
Started: Sep 1, 2025 · Completed: Jan 31, 2027
1 condition5 sponsors0 locations
NCT06956807
Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells
PHASE1Not yet recruiting
10 participants
Started: Sep 1, 2025 · Completed: Jun 30, 2027
3 conditions5 sponsors1 location
NCT07061080
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
PHASE2Not yet recruiting
87 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors19 locations
NCT07105111
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
PHASE4Recruiting
50 participants
Started: Aug 29, 2025 · Completed: Apr 30, 2027
5 conditions1 sponsor8 locations
NCT06882317
Long Term Follow-up Study for Subjects Administered CLBR001
N/AEnrolling by invitation
40 participants
Started: Aug 28, 2025 · Completed: Feb 29, 2044
1 condition1 sponsor1 location
NCT07001748
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
PHASE2/PHASE3Active, not recruiting
148 participants
Started: Aug 19, 2025 · Completed: May 30, 2030
3 conditions2 sponsors10 locations
NCT07196501
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
PHASE3Recruiting
550 participants
Started: Aug 18, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor4 locations
NCT07105098
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
PHASE3Recruiting
284 participants
Started: Aug 11, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor5 locations
NCT06974786
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
PHASE2Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Apr 30, 2033
2 conditions3 sponsors3 locations
NCT07089342
Exploring Biological Markers of Driver Fatigue for Enhanced Road Safety
N/ARecruiting
500 participants
Started: Jul 31, 2025 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT07077967
Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs
N/ANot yet recruiting
100 participants
Started: Jul 15, 2025 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
PHASE3Recruiting
800 participants
Started: Jul 11, 2025 · Completed: Dec 31, 2031
1 condition1 sponsor24 locations
NCT06590285
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
NARecruiting
60 participants
Started: Jul 1, 2025 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT07060196
The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
N/ANot yet recruiting
70 participants
Started: Jun 30, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06184659
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
PHASE4Recruiting
5,800 participants
Started: Jun 26, 2025 · Completed: Mar 30, 2029
2 conditions1 sponsor2 locations
NCT07078370
Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass
NAEnrolling by invitation
20 participants
Started: Jun 16, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors2 locations
NCT06878664
Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
PHASE3Recruiting
166 participants
Started: Jun 12, 2025 · Completed: Jan 31, 2029
1 condition2 sponsors21 locations
NCT07141992
Comparison of Active vs Passive Neural Mobilizations Effects in Improving Burning Pain, Muscular Strength, and Range of Motion in Patients With Diabetic Neuropathy
NAEnrolling by invitation
60 participants
Started: Jun 4, 2025 · Completed: Sep 1, 2025
3 conditions2 sponsors1 location
NCT07008742
Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
N/ARecruiting
100 participants
Started: Jun 4, 2025 · Completed: Jun 1, 2029
6 conditions5 sponsors1 location
NCT06876571
Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay
N/ANot yet recruiting
250 participants
Started: Jun 2, 2025 · Completed: Dec 6, 2025
1 condition1 sponsor3 locations
NCT06913608
A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases
PHASE1Not yet recruiting
12 participants
Started: May 31, 2025 · Completed: Aug 31, 2028
3 conditions1 sponsor0 locations
NCT06963021
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
PHASE3Recruiting
200 participants
Started: May 30, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor9 locations
NCT07209033
FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration.
NARecruiting
80 participants
Started: May 29, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors1 location